Steven A. Pergam, MD, MPH | Allergy and Infectious Diseases

Associate Professor

Department of Medicine, Division of Allergy and Infectious Diseases

Adjunct Associate Professor

Department of Epidemiology, School of Public Health

Medical Director of Infection Prevention, Seattle Cancer Care Alliance

Associate Member, Vaccine and Infectious Disease and Clinical Research Divisions, Fred Hutchinson Cancer Research Center

Faculty Information

Biography

Dr. Pergam's research focuses on the prevention of infections in patients with cancer, transplant recipients, and other immunocompromised populations. He focuses on the immunogenetics of innate responses to Cytomegalovirus in hematopoietic cell transplant recipients. Current studies include the evaluation of natural killer associated KIR and CMV outcomes post-transplant. He has research programs that are currently evaluating the use of viral kinetics and advanced diagnostics to improve diagnosis of CMV complications. Dr. Pergam also has an interest in the epidemiology and prevention of viral infections in cord blood transplant recipients and other high-risk HCT populations.

As the Director of Infection Control, Dr. Pergam is actively involved in the development of new infection control strategies and educational programs. He has active research projects that aim to better understand the epidemiology of nosocomial bacterial infections and respiratory viruses in cancer patients.

Education & Training:

University of Nebraska School of Medicine

Omaha NE

1994-1998

MPH, Epidemiology

University of Washington, School of Public Health

Seattle WA

2005-2008

Residency

University of New Mexico

Albuquerque NM

1998-2001

Fellowship in Infectious Diseases

University of Washington

Seattle WA

2005-2009

Honors:

Alpha Omega Alpha, Clinical Excellence Award

1998

William Hardy Teaching Award, Internal Medicine Attending of the Year University of New Mexico, Albuquerque, NM

2003-2004

Infectious Diseases Society of America Fellows Travel Award

2007

Elected to Fellow, Infectious Disease Society of America (FIDSA)

2014

Contact

Email:

spergam@fhcrc.org

Mailing Address:

Fred Hutchinson Cancer Research Center

1100 Fairview Ave. N

Box 358080

Seattle, WA 98109

Publications

PubMed:

PubMed Bibliography

Publications:

Pergam SA, Xie H, Sandhu R, et al. Efficiency and risk factors for CMV transmission in seronegative hematopoietic stem cell recipients. Biol Blood Marrow Transplant. 2012;18(9):1391-400.
• PubMed Abstract

Milano F, Pergam SA, Xie H, et al. Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients. Blood. 2011; 118(20), 5689-96. PMID: 21937692. PMCID: PMC3217367.

• PubMed Abstract

Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010; 363(22): 2091-101. PMID: 21105791. PMCID: PMC3017343.
• PubMed Abstract

Pergam SA, Forsberg CW, Boeckh MJ, et al. (2011). Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients. Transpl Infect Dis. 2011; 13(1); 15-23. PMID: 20636480. PMCID: PMC2976841.
• PubMed Abstract

Travi G, Pergam SA, Xie H, et al. The effect of imatinib on cytomegalovirus reactivation in hematopoietic cell transplantation. Clin Infect Dis. 2009; 49(11); e120-3. PMID:19886798.

PMCID: PMC2779734.
• PubMed Abstract

Printer-friendly